ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,269.67
1.02%
Dow Jones
39,935.07
0.00%
Gold vs US Dollar
2,376.215
0.50%
Brent Oil
80.75
-0.96%
Bitcoin
67,363.11
2.39%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Biogen Inc (IDP) Share Price

IDP Biogen Inc

199.80
-10.10 (-4.81%)
14:24:08 - Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Biogen Inc TG:IDP Tradegate (DE) Ordinary Share  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   -10.10 -4.81 199.80 193.85 196.95 210.00 193.05 209.9 606 13:24:08   
 Type  Size  Price  Time  Units 
  1 199.80 13:05:32 EUR
 
Recent News
DateTimeSource
HeadlineMore IDP News
26/07/202412:20UKREGUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
02/07/202414:16GLOBEBiogen Completes Acquisition of Human Immunology Biosciences
28/06/202400:39GLOBE“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
24/06/202412:30GLOBETOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
10/06/202400:37GLOBEFDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
30/05/202421:51GLOBEBiogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
22/05/202412:30GLOBEBiogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
26/01/202309:44PBBInnovaderma838
31/03/202211:50PBBInnovaderma - Global Brands & Products for Beauty, Personal Care & Life Science386
01/08/202119:18PBBInnovaderma - Global Brands & Products for Beauty, Personal Care & Life Science1
26/07/202115:06PBBInnovaderma - Global Brands and Huge Markets23,282
27/04/202110:06PBBTime to Look at InnovaDerma (IDP)5
11/08/201813:02PBBThings to note4
11/08/201813:02PBBSome interesting posts2
Data Downloads for IDP

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Biogen Inc Articles